Exposure to Temozolmide in the First Trimester of Pregnancy in a Young Woman With Glioblastoma Multiforme

Literature on the outcome of pregnancy with first trimester exposure to Temozolomide is limited. We describe the case of a young woman with Glioblastoma Multiforme who was exposed to Temozolomide during her first trimester of pregnancy and subsequently delivered a healthy term newborn. At six months...

Descripción completa

Detalles Bibliográficos
Autores principales: Nolan, Bernadette, Balakrishna, Madhuri, George, Mathew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649807/
https://www.ncbi.nlm.nih.gov/pubmed/29147320
http://dx.doi.org/10.4021/wjon570w
_version_ 1783272607573868544
author Nolan, Bernadette
Balakrishna, Madhuri
George, Mathew
author_facet Nolan, Bernadette
Balakrishna, Madhuri
George, Mathew
author_sort Nolan, Bernadette
collection PubMed
description Literature on the outcome of pregnancy with first trimester exposure to Temozolomide is limited. We describe the case of a young woman with Glioblastoma Multiforme who was exposed to Temozolomide during her first trimester of pregnancy and subsequently delivered a healthy term newborn. At six months of age, the child remains healthy with no evidence of Temozolomide related effects.
format Online
Article
Text
id pubmed-5649807
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Elmer Press
record_format MEDLINE/PubMed
spelling pubmed-56498072017-11-16 Exposure to Temozolmide in the First Trimester of Pregnancy in a Young Woman With Glioblastoma Multiforme Nolan, Bernadette Balakrishna, Madhuri George, Mathew World J Oncol Case Report Literature on the outcome of pregnancy with first trimester exposure to Temozolomide is limited. We describe the case of a young woman with Glioblastoma Multiforme who was exposed to Temozolomide during her first trimester of pregnancy and subsequently delivered a healthy term newborn. At six months of age, the child remains healthy with no evidence of Temozolomide related effects. Elmer Press 2012-12 2013-01-04 /pmc/articles/PMC5649807/ /pubmed/29147320 http://dx.doi.org/10.4021/wjon570w Text en Copyright 2012, Nolan et al. http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Nolan, Bernadette
Balakrishna, Madhuri
George, Mathew
Exposure to Temozolmide in the First Trimester of Pregnancy in a Young Woman With Glioblastoma Multiforme
title Exposure to Temozolmide in the First Trimester of Pregnancy in a Young Woman With Glioblastoma Multiforme
title_full Exposure to Temozolmide in the First Trimester of Pregnancy in a Young Woman With Glioblastoma Multiforme
title_fullStr Exposure to Temozolmide in the First Trimester of Pregnancy in a Young Woman With Glioblastoma Multiforme
title_full_unstemmed Exposure to Temozolmide in the First Trimester of Pregnancy in a Young Woman With Glioblastoma Multiforme
title_short Exposure to Temozolmide in the First Trimester of Pregnancy in a Young Woman With Glioblastoma Multiforme
title_sort exposure to temozolmide in the first trimester of pregnancy in a young woman with glioblastoma multiforme
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649807/
https://www.ncbi.nlm.nih.gov/pubmed/29147320
http://dx.doi.org/10.4021/wjon570w
work_keys_str_mv AT nolanbernadette exposuretotemozolmideinthefirsttrimesterofpregnancyinayoungwomanwithglioblastomamultiforme
AT balakrishnamadhuri exposuretotemozolmideinthefirsttrimesterofpregnancyinayoungwomanwithglioblastomamultiforme
AT georgemathew exposuretotemozolmideinthefirsttrimesterofpregnancyinayoungwomanwithglioblastomamultiforme

Ejemplares similares